CVR 27757103Private limited company (ApS)Fremstilling af farmaceutiske råvarer (211000)VojensFounded 24 May 2004
Employees
1
CVR registry, 2020
Gross profit
1.7M
DKK, annual report 2025
+209.9% on 2024
Result
+569.7K
DKK, annual report 2025
Equity
1.3M
DKK, annual report 2025
Dandex has recorded no changes to this company since it began following the register.
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about PRECISE INGREDIENTS ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexPHARMA NORD ApSCVR 67303016, 100% of capital and votes, since 24 May 2004
Eli Wallinsince 24 May 2004
CVR 67303016100% of capital and votessince 24 May 2004
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
Ultimate controller
Holds 100% of capital and votes in PHARMCO I ApS, since 4 Feb 2000
Holding company
CVR 25204042Private limited company (ApS)
Holds 50% to under 66.7% of capital and votes in PHARMA NORD ApS, since 4 Feb 2000
Holding company
CVR 67303016Private limited company (ApS)
Holds 100% of capital and votes in PRECISE INGREDIENTS ApS, since 24 May 2004
This company
PRECISE INGREDIENTS ApS
CVR 27757103
CVR records founders at incorporation. It does not record whether they are alive or still involved.
24 May 2004 to 2 Nov 2026.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Gross profit | 196 | 196 | 597 | 545 | 1,689 |
| Operating profit | +152 | +196 | +597 | +545 | +1,689 |
| Result for the year | +181 | +268 | +377 | +582 | +570 |
| Equity | 307 | 576 | 952 | 714 | 1,284 |
| Total assets | 1,648 | 900 | 2,048 | 1,100 | 2,344 |
| Employees (average) | 1 | 0 | Not reported | 0 | 0 |
| Credit metrics (Dandex calculations) | |||||
| Gross profit growth (vækst i bruttofortjeneste) | -40.6% | 0.5% | 204.5% | -8.7% | 209.9% |
| EBITDA | 153 | Not reportednote 1 | Not reportednote 1 | Not reportednote 1 | Not reportednote 1 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) | 78% | Not reportednote 1 | Not reportednote 1 | Not reportednote 1 | Not reportednote 1 |
| Employee growth (vækst i antal ansatte) | 0% | -100% | Not reportednote 2 | n.m.note 3 | n.m.note 3 |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | -119 | -148 | -332 | -89note 4 | -86 |
| Gearing, NIBD / EBITDA | Net cash | Not reportednote 1 | Not reportednote 1 | Not reportednote 1 | Not reportednote 1 |
| ROIC (afkast af investeret kapital) | 17.4% | 49.7% | 88.9% | 68.3%note 4 | 144.5% |
| NIBD incl. group and owner balances (NIBD inkl. koncern- og ejermellemværender) | -1,648 | -701 | -2,048 | -1,100note 4 | -2,123 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may. No cash flow statement filed (class A and B are exempt).
Annual report 2025
1 Jan 2025 to 31 Dec 2025, published 9 Jun 2026
Annual report 2024
1 Jan 2024 to 31 Dec 2024, published 12 Jun 2025
Annual report 2023
1 Jan 2023 to 31 Dec 2023, published 12 Jun 2024
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 12 Jun 2023
Annual report 2021
1 Jan 2021 to 31 Dec 2021, published 14 Jun 2022
2 registered in CVR.
P-number 1010591100Tinglykke 10, 6500 Vojens
P-number 1014954178Tinglykke 10, 6500 Vojens
